Monday, May 20, 1996
Most diagnostics don't lend themselves to broad marketing programs. But
as increasingly sophisticated biology leads to novel diagnostics, more companies will need
to educate their marketplace about the new tests.
Metra Biosystems Inc. has launched such a program, called Baseline,
offering physicians the ability to test patients with the Pyrilinks-D urinary assay at no
cost through June 15. Pyrilinks-D measures bone resorption,to identify patients at risk
for increased bone loss, and can help monitor the efficacy of anti-resorptive therapies.